FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
October 10, 2023 3 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO
Read MoreOctober 09, 2023 2 min read Source/Disclosures Published by: Disclosures: Diekema reports receiving grant funding from bioMerieux, Inc. and consulting
Read MoreRon Irby expected the artificial knee implanted in his right leg in September 2018 would last two decades — perhaps
Read MoreThomas Kurian, CEO of Google Cloud, speaks at a cloud computing conference held by the company in 2019. Michael Short
Read MoreOctober 09, 2023 2 min read Source/Disclosures Published by: Disclosures: Chemaly reports no relevant financial disclosures. ADD TOPIC TO EMAIL
Read MoreCNBC’s Jim Cramer on Monday suggested that investors keep an eye on Vertex Pharmaceuticals (VRTX), a biotechnology company developing a
Read MoreAlmost 30 million Americans take aspirin for primary or secondary prevention of cardiovascular disease (CVD) or colorectal cancer (CRC).1 For
Read MoreOctober 03, 2023 2 min read Source/Disclosures Published by: Disclosures: Gottdenker reports no relevant financial disclosures. ADD TOPIC TO EMAIL
Read MoreOctober 05, 2023 2 min read Source/Disclosures Published by: Disclosures: Smith reports no relevant financial disclosures. Please see the study
Read MorePhilips office building in Warsaw, Poland on July 29, 2021. (Photo by Beata Zawrzel/NurPhoto via Getty Images) Nurphoto | Nurphoto
Read More